Impact of Systemic Venous Congestion in Heart Failure

作者: Matthias Dupont , Wilfried Mullens , W. H. Wilson Tang

DOI: 10.1007/S11897-011-0071-7

关键词: Heart failureMedicineCardiac surgeryCardiorenal syndromeVascular surgeryPerfusionMyocardial infarctionInternal medicineHemofiltrationCardiologyEdema

摘要: Systemic venous congestion is one of the hallmarks syndrome heart failure that results from activation different deleterious neurohormonal pathways. Apart contributing to patients' symptoms and hospital admissions, growing evidence suggests itself drives further progression. In addition, systemic exerts detrimental effects on other organs (such as kidneys liver) due ineffective organ perfusion. Endothelial cell activation, altered ventricular geometry, functional mitral insufficiency are among proposed mechanisms. Diuretics vasodilators remain mainstay treatment options, mostly because poor understanding underlying cardiorenal mechanisms involved. Recently, ultrafiltration has emerged an invasive option in setting diuretic resistance. Congestion ideally should be prevented, often initially through water salt restriction. Early detection, possibly with help novel implantable sensor technology, may allow for early detection intervention long before overt established.

参考文章(63)
Robert C Bourge, William T Abraham, Philip B Adamson, Mark F Aaron, Juan M Aranda, Anthony Magalski, Michael R Zile, Andrew L Smith, Frank W Smart, Mark A O’Shaughnessy, Mariell L Jessup, Brandon Sparks, David L Naftel, Lynne Warner Stevenson, COMPASS-HF study group, None, Randomized Controlled Trial of an Implantable Continuous Hemodynamic Monitor in Patients With Advanced Heart Failure: The COMPASS-HF Study Journal of the American College of Cardiology. ,vol. 51, pp. 1073- 1079 ,(2008) , 10.1016/J.JACC.2007.10.061
Clyde W Yancy, Margarita Lopatin, Lynne Warner Stevenson, Teresa De Marco, Gregg C Fonarow, ADHERE Scientific Advisory Committee and Investigators, Clinical Presentation, Management, and In-Hospital Outcomes of Patients Admitted With Acute Decompensated Heart Failure With Preserved Systolic Function: A Report From the Acute Decompensated Heart Failure National Registry (ADHERE) Database Journal of the American College of Cardiology. ,vol. 47, pp. 76- 84 ,(2006) , 10.1016/J.JACC.2005.09.022
K HOGG, J MCMURRAY, Neurohumoral Pathways in Heart Failure With Preserved Systolic Function Progress in Cardiovascular Diseases. ,vol. 47, pp. 357- 366 ,(2005) , 10.1016/J.PCAD.2005.02.001
Mark H. Drazner, J. Eduardo Rame, Lynne W. Stevenson, Daniel L. Dries, Prognostic Importance of Elevated Jugular Venous Pressure and a Third Heart Sound in Patients with Heart Failure The New England Journal of Medicine. ,vol. 345, pp. 574- 581 ,(2001) , 10.1056/NEJMOA010641
Anjali Ganda, Duygu Onat, Ryan T. Demmer, Elaine Wan, Timothy J. Vittorio, Hani N. Sabbah, Paolo C. Colombo, Venous Congestion and Endothelial Cell Activation in Acute Decompensated Heart Failure Current Heart Failure Reports. ,vol. 7, pp. 66- 74 ,(2010) , 10.1007/S11897-010-0009-5
Wilfried Mullens, Zuheir Abrahams, Gary S. Francis, George Sokos, Randall C. Starling, James B. Young, David O. Taylor, W.H. Wilson Tang, Usefulness of Isosorbide Dinitrate and Hydralazine as Add-on Therapy in Patients Discharged for Advanced Decompensated Heart Failure American Journal of Cardiology. ,vol. 103, pp. 1113- 1119 ,(2009) , 10.1016/J.AMJCARD.2008.12.028
George T Lau, Hiok C Tan, Leonard Kritharides, Type of liver dysfunction in heart failure and its relation to the severity of tricuspid regurgitation. American Journal of Cardiology. ,vol. 90, pp. 1405- 1409 ,(2002) , 10.1016/S0002-9149(02)02886-2
Milton Packer, The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. Journal of the American College of Cardiology. ,vol. 20, pp. 248- 254 ,(1992) , 10.1016/0735-1097(92)90167-L